Category: Prostate Cancer In Focus
Biomarkers and Novel PET Imaging to Detect Neuroendocrine Prostate Cancer
H&O What is neuroendocrine prostate cancer (NEPC), and how common is it? RA NEPC is an aggressive histologic subtype of prostate cancer. The de novo form […]
Overcoming Immune Evasion in Advanced Prostate Cancer
H&O Why do some patients with prostate cancer respond to immune checkpoint inhibitors (ICIs), whereas others do not? AA Several clinical trials with ICIs, either alone […]
More Highlights in Prostate Cancer From the 2023 American Society of Clinical Oncology Annual Meeting
June 2-6, 2023 • Chicago, Illinois and Virtual Last month, Clinical Advances in Hematology & Oncology highlighted the PEACE-1 trial, the TALAPRO-2 study, and research on […]
Predictive Biomarkers in Advanced Prostate Cancer
H&O What is the difference between a prognostic biomarker and a predictive biomarker? AA Prognostic biomarkers estimate the natural history of a disease, or in other […]
The Use of AI to Identify Predictive, Pathology-Based Biomarkers in Men With Prostate Cancer
H&O How is artificial intelligence (AI) defined in the context of cancer biomarkers, including predictive biomarkers? DS AI is a very general term, of course, that […]
When to Use Somatic Tumor Testing in Prostate Cancer
H&O Which patients with prostate cancer are eligible for somatic tumor testing? TF To begin with, we should be clear about some definitions. Somatic tumor testing […]
Update on Metastatic Hormone-Sensitive Prostate Cancer
H&O How often do men present with de novo metastatic prostate cancer? KC In places where we do a lot of screening, such as the United […]
Special Concerns for Survivors of Prostate Cancer
Clinical Advances in Hematology & Oncology Volume 14, Issue 9, September 2016 Andrew C. Peterson, MD Professor of Urologic Surgery Duke University School of Medicine Durham, […]
The Timing of Radium-223 Therapy in Castration-Resistant Prostate Cancer
Clinical Advances in Hematology & Oncology Volume 13, Issue 9, September 2015 Oliver Sartor, MD LaBorde Professor for Cancer Research Medical Director Tulane Cancer Center Departments of […]